Technology News and Research

RSS

Cardinal Health patents disposable Nitrile gloves

Tillotson Corp. today announced that Cardinal Health has licensed a Tillotson U.S. patent for disposable Nitrile Gloves.

21 Sep 2009

Research combining magnetism and nanotechnology

Researchers led by Daniel Kohane, MD, PhD of Children's Hospital Boston, funded by the National Institutes of Health, have devised a solution that combines magnetism with nanotechnology.

21 Sep 2009

Center for Hip Pain and Preservation focuses on improved understanding of hip abnormalities

Recent improved understanding of hip abnormalities, combined with advances in diagnostic imaging techniques and minimally invasive surgical treatments are giving many patients new hope for relieving chronic, misdiagnosed hip pain.

21 Sep 2009

Maximum Weight Limit is the new measure to calculate healthy weight

So, using SAS software and statistical procedures, he discovered a much simpler way of calculating a Maximum Weight Limit, which closely corresponds to weight recommendations listed on BMI charts. But, you don't need to calculate or know your BMI, nor do you need a chart or online calculator to figure out your Maximum Weight Limit. Fernandez will present his Maximum Weight Limit calculation at the Nevada Public Health Association Conference, 1:30 p.m., Sept. 22 at the University of Nevada, Reno's Joe Crowley Student Union, Room 423.

21 Sep 2009

Panel discussion on best practices for funding new mobile infrastructure

InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it will present at a panel discussion as part of Mobile Monday Mid-Atlantic, Monday September 21, 2009 at 5:30 PM, at the Union League in Philadelphia.

19 Sep 2009

H1N1 infected people continue to shed live virus days after the symptoms

ABC News and other outlets are reporting that two studies released on Tuesday suggest that people infected with the H1N1 virus continue to shed virus after the point where current recommendations say they can resume their normal activities.

19 Sep 2009

Health experts to discuss innovative breakthroughs to solve health issues in poor communities

New ideas, systems and technologies are emerging to solve numerous health challenges facing the world’s poorest communities. Some of the foremost experts on global health will discuss these and the prospects for health breakthroughs in the developing world at a media briefing at the Conrad N. Hilton Humanitarian Symposium at 2:30 pm on Monday, September 21.

19 Sep 2009

Medtronic to showcase cardiovascular product portfolio at TCT 2009

Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world’s premier annual meeting for interventional cardiologists.

19 Sep 2009

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend MedAxiom’s Fall Conference in Dana Point, California September 23rd, 2009 to promote their cardiac optimized PET scanner, the Attrius™ (www.medaxiom.com).

19 Sep 2009

NovoStent completes enrollment for its SAMBA Stent and Delivery System trial

NovoStent Corporation, a privately held medical device company, today announced the completion of enrollment earlier this summer in the company’s European clinical trial evaluating the use of its SAMBATM Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease.

19 Sep 2009

Newcardio raises funds through private placement

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that it closed a private placement financing with institutional and other accredited investors, including members of NewCardio's management team and board of directors, who purchased over half of the offering.

19 Sep 2009

Opinion poll reveals biotechnology is the way for Canada’s future prosperity

Nine out of ten Canadians believe biotechnology is important to Canada’s future prosperity and eight out of ten supported grants to emerging companies, according to BIOTECanada’s annual opinion poll, released at the launch of National Biotechnology Week.

19 Sep 2009

Experts’ comments on America's obesity epidemic

As a recent Newsweek article states, "it's hardly clear that there actually is an obesity epidemic, or that fat people are at greater risk of death than people of normal weight, or that weight loss—relentlessly promoted by public-health officials as the solution to America's weight problem—is an attainable goal at all."

19 Sep 2009

Rodman & Renshaw acted as exclusive placement agent for Spectrum’s transaction

Rodman & Renshaw Capital Group, Inc., today announced that its client Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus in oncology, has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.

19 Sep 2009

Patient enrollment for PLATINUM workhorse trial completed by Boston Scientific

Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the workhorse portion of its PLATINUM clinical program. PLATINUM is a global, randomized, pivotal controlled trial designed to support U.S. Food and Drug Administration (FDA) and Japanese Ministry of Health, Labor and Welfare (MHLW) approval of the platinum chromium PROMUS((R)) Element(TM) Everolimus-Eluting Coronary Stent System.

19 Sep 2009

Human Identification symposium discusses DNA technology advancement

The 20th International Symposium on Human Identification will highlight advances in DNA technology and explore controversial issues brought about by the expanded power and use of DNA typing.

19 Sep 2009

Bioniche announces fiscal 2009 year-end results

Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2009 fiscal year ended June 30, 2009.

19 Sep 2009

New ultra-thin adhesives introduced by Avery Dennison Specialty Tape Division

Avery Dennison Specialty Tape Division, an innovative leader in adhesive materials for the medical sector, introduced two new ultra-thin adhesives and a hydrocolloid and adhesive technology solution at MEDTEC China this week.

19 Sep 2009

Precise Biometrics successfully completes rights issue with preferential rights

Precise Biometrics AB has successfully completed a rights issue with preferential rights, which has supplied the Company with SEK 54.0 million prior to issue costs. The rights issue was subscribed to 178% and is implemented to finance further expansion and increase market penetration in prioritized segments.

18 Sep 2009

Research program to study personalized medicine

A new collaborative research program that will use the power of metabolomic profiling to help advance the concept of personalized medicine was announced September 17, 2009 by the Burnham Institute for Medical Research and the Sarah W. Stedman Nutrition and Metabolism Center at Duke University Medical Center.

18 Sep 2009